GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 114 Standalone Balance Sheet as at March 31, 2022 ( ` in lakhs) Notes As at March 31, 2022 As at March 31, 2021 ASSETS Non-current assets Property, plant and equipment 3 277,37.03 310,93.21 Right of use assets 48 17,57.48 31,26.43 Capital work-in-progress 3 30,50.21 13,21.43 Investment property 4 1,18.49 1,32.87 Intangible assets 5 34,49.74 43,36.40 Financial assets (i) Investments 6 24,49.31 24,49.31 (ii) Loans 7 204,60.00 - (iii) Other financial assets 8 11,04.84 12,07.55 Current tax assets (net) 47 192,87.56 341,52.93 Deferred tax assets (net) 47 112,78.38 101,66.93 Other non-current assets 9 44,95.64 45,88.02 951,88.68 925,75.08 Current assets Inventories 10 512,71.32 523,33.85 Financial assets (i) Current Investments 11 365,59.23 - (ii) Trade receivables 12 205,23.89 215,60.46 (iii) Cash and cash equivalents 13 280,79.12 404,90.20 (iv) Bank balances other than (iii) above 14 2198,32.07 752,77.48 (v) Other financial assets 15 63,05.83 19,20.27 Other current assets 16 44,88.42 75,38.46 3670,59.88 1991,20.72 Assets classified as held for sale 17 11.23 180,11.84 3670,71.11 2171,32.56 TOTAL ASSETS 4622,59.79 3097,07.64 EQUITY AND LIABILITIES EQUITY Equity share capital 18 169,40.60 169,40.60 Other equity 19 2508,21.14 1327,70.90 Total equity 2677,61.74 1497,11.50 LIABILITIES Non-current liabilities Financial liabilities (i) Lease liabilities 20 & 48 7,62.35 20,24.99 (ii) Other financial liabilities 21 2,04.46 2,04.46 Provisions 22 & 29 260,95.83 258,24.55 270,62.64 280,54.00 Current liabilities Financial liabilities (i) Borrowings 23 - 2.40 (ii) Lease liabilities 24 & 48 12,45.30 14,35.27 (iii) Trade payables 25 Total outstanding dues of micro enterprises and small enterprises 7,74.40 5,26.94 Total outstanding dues of creditors other than micro enterprises and small enterprises 538,88.55 442,71.91 (iv) Other financial liabilities 26 133,50.57 171,87.83 Other current liabilities 27 357,58.36 246,83.26 Provisions 28 & 29 327,97.88 274,62.27 Current tax liabilities (net) 47 296,20.35 163,72.26 1674,35.41 1319,42.14 Total liabilities 1944,98.05 1599,96.14 TOTAL EQUITY AND LIABILITIES 4622,59.79 3097,07.64 The accompanying notes 1 to 63 are an integral part of the Standalone Financial Statements In terms of our report attached For Deloitte Haskins & Sells LLP For and on behalf of the Board of Directors Chartered Accountants R. S. Karnad Chairperson DIN: 00008064 Firm‘s Registration No. 117366W/W-100018 S. Venkatesh Managing Director DIN: 07263117 J. Chandy CFO & Whole-time Director DIN: 09530618 Rupen K. Bhatt D. Sundaram Audit Committee Chairman DIN: 00016304 Partner A. Nadkarni Company Secretary FCS 10460 Membership No. 046930 Mumbai, May 16, 2022 Mumbai, May 16, 2022